Bernhard J. Jank

893 total citations
31 papers, 653 citations indexed

About

Bernhard J. Jank is a scholar working on Oncology, Surgery and Otorhinolaryngology. According to data from OpenAlex, Bernhard J. Jank has authored 31 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Surgery and 11 papers in Otorhinolaryngology. Recurrent topics in Bernhard J. Jank's work include Head and Neck Cancer Studies (11 papers), Salivary Gland Tumors Diagnosis and Treatment (7 papers) and Inflammatory Biomarkers in Disease Prognosis (5 papers). Bernhard J. Jank is often cited by papers focused on Head and Neck Cancer Studies (11 papers), Salivary Gland Tumors Diagnosis and Treatment (7 papers) and Inflammatory Biomarkers in Disease Prognosis (5 papers). Bernhard J. Jank collaborates with scholars based in Austria, United States and United Kingdom. Bernhard J. Jank's co-authors include Harald C. Ott, Jacques P. Guyette, Philipp T. Moser, Joshua R. Gershlak, Glenn R. Gaudette, Gregor Heiduschka, Jonathan M. Charest, Sarah E. Gilpin, Robert W. Mills and Tatsuya Okamoto and has published in prestigious journals such as Biomaterials, Circulation Research and Oncogene.

In The Last Decade

Bernhard J. Jank

31 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernhard J. Jank Austria 12 428 298 189 172 113 31 653
Kaiyuan Jiang China 12 258 0.6× 49 0.2× 135 0.7× 90 0.5× 50 0.4× 32 482
Lan Zhu China 11 89 0.2× 81 0.3× 55 0.3× 90 0.5× 64 0.6× 23 455
Zurab Kakabadze Georgia 14 267 0.6× 97 0.3× 80 0.4× 90 0.5× 18 0.2× 39 457
Junji Komori Japan 13 587 1.4× 246 0.8× 213 1.1× 153 0.9× 121 1.1× 26 835
Noah S. Nelson United States 14 166 0.4× 17 0.1× 93 0.5× 95 0.6× 119 1.1× 55 539
Reena Khianey United States 6 291 0.7× 108 0.4× 166 0.9× 46 0.3× 21 0.2× 13 449
Dorien M. Tiemessen Netherlands 17 336 0.8× 242 0.8× 133 0.7× 124 0.7× 172 1.5× 32 727
Zhenyu Ding China 11 84 0.2× 94 0.3× 144 0.8× 62 0.4× 125 1.1× 34 443
Wei-Wen Lin Taiwan 12 453 1.1× 353 1.2× 190 1.0× 181 1.1× 28 0.2× 27 721
Marta Miyazawa Brazil 11 151 0.4× 76 0.3× 288 1.5× 85 0.5× 140 1.2× 21 799

Countries citing papers authored by Bernhard J. Jank

Since Specialization
Citations

This map shows the geographic impact of Bernhard J. Jank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard J. Jank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard J. Jank more than expected).

Fields of papers citing papers by Bernhard J. Jank

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard J. Jank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard J. Jank. The network helps show where Bernhard J. Jank may publish in the future.

Co-authorship network of co-authors of Bernhard J. Jank

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard J. Jank. A scholar is included among the top collaborators of Bernhard J. Jank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard J. Jank. Bernhard J. Jank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brkic, Faris F., et al.. (2023). The ATR inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell lines. Investigational New Drugs. 41(6). 842–850. 2 indexed citations
2.
Jank, Bernhard J., et al.. (2023). High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients. Journal of Cancer Research and Clinical Oncology. 149(12). 10675–10683. 1 indexed citations
3.
4.
Jank, Bernhard J., et al.. (2023). Targeting TGF beta receptor 1 in head and neck squamous cell carcinoma. Oral Diseases. 30(3). 1114–1127. 4 indexed citations
5.
Fuereder, Thorsten, Faris F. Brkic, Nicholas J. Campion, et al.. (2023). Low free triiodothyronine and immune-related hyperthyroidism are associated with overall and progression-free survival in head and neck squamous cell carcinoma treated with pembrolizumab. International Immunopharmacology. 123. 110799–110799. 2 indexed citations
6.
7.
Jank, Bernhard J., et al.. (2022). Protein Expression of Folate Receptor Alpha in Adenoid Cystic Carcinoma of the Head and Neck. OncoTargets and Therapy. Volume 15. 531–538. 3 indexed citations
8.
Jank, Bernhard J., et al.. (2021). Prognostic Relevance of Thyroid-Hormone-Associated Proteins in Adenoid Cystic Carcinoma of the Head and Neck. Journal of Personalized Medicine. 11(12). 1352–1352. 3 indexed citations
9.
Jank, Bernhard J., et al.. (2021). Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma. Investigational New Drugs. 40(2). 224–231. 6 indexed citations
10.
Campion, Nicholas J., et al.. (2021). The molecular march of primary and recurrent nasopharyngeal carcinoma. Oncogene. 40(10). 1757–1774. 28 indexed citations
11.
Kadletz, Lorenz, Bernhard J. Jank, Felicitas Oberndorfer, et al.. (2020). Expression of inhibitors of apoptosis proteins in salivary gland adenoid cystic carcinoma: XIAP is an independent marker of impaired cause‐specific survival. Clinical Otolaryngology. 45(3). 364–369. 4 indexed citations
12.
13.
Jank, Bernhard J., et al.. (2019). Prognostic value of advanced lung cancer inflammation index in head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology. 276(5). 1487–1492. 20 indexed citations
14.
Moser, Philipp T., M Gerli, Gillian R. Diercks, et al.. (2019). Creation of Laryngeal Grafts from Primary Human Cells and Decellularized Laryngeal Scaffolds. Tissue Engineering Part A. 26(9-10). 543–555. 14 indexed citations
15.
Kadletz, Lorenz, Faris F. Brkic, Bernhard J. Jank, et al.. (2019). AF1q Expression Associates with CD44 and STAT3 and Impairs Overall Survival in Adenoid Cystic Carcinoma of the Head and Neck. Pathology & Oncology Research. 26(2). 1287–1292. 3 indexed citations
16.
Brkic, Faris F., Lorenz Kadletz, Bernhard J. Jank, et al.. (2019). Impact of pretherapeutic neutrophil-to-lymphocyte ratio, serum albumin, body-mass index, and advanced lung cancer inflammation index on clinical outcome in sinonasal squamous cell carcinoma. Journal of Cranio-Maxillofacial Surgery. 48(1). 33–37. 14 indexed citations
17.
Brkic, Faris F., Lorenz Kadletz, Bernhard J. Jank, et al.. (2018). Pretreatment assessment of hematologic and inflammatory markers in adenoid cystic carcinoma: neutrophil/lymphocyte ratio is associated with multiple recurrences. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 127(5). 408–416. 13 indexed citations
18.
Jank, Bernhard J., Jeremy Goverman, Jacques P. Guyette, et al.. (2017). Creation of a Bioengineered Skin Flap Scaffold with a Perfusable Vascular Pedicle. Tissue Engineering Part A. 23(13-14). 696–707. 35 indexed citations
19.
Ren, Xi, Luis F. Tapias, Bernhard J. Jank, et al.. (2015). Ex vivo non-invasive assessment of cell viability and proliferation in bio-engineered whole organ constructs. Biomaterials. 52. 103–112. 42 indexed citations
20.
Jank, Bernhard J., Linjie Xiong, Philipp T. Moser, et al.. (2015). Engineered composite tissue as a bioartificial limb graft. Biomaterials. 61. 246–256. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaiyuan Jiang Breakdown of academic impact, for papers by Lan Zhu Breakdown of academic impact, for papers by Zurab Kakabadze Breakdown of academic impact, for papers by Junji Komori Breakdown of academic impact, for papers by Noah S. Nelson Breakdown of academic impact, for papers by Reena Khianey Breakdown of academic impact, for papers by Dorien M. Tiemessen Breakdown of academic impact, for papers by Zhenyu Ding Breakdown of academic impact, for papers by Wei-Wen Lin Breakdown of academic impact, for papers by Marta Miyazawa
Rankless by CCL
2026